Citations

Clear

2 citation(s) found for "Skrifvars, M B".

The effect of low- and high-mean arterial pressure levels on short-term mortality in cardiac arrest and cardiogenic shock due to acute myocardial infarction: a meta-analysis
Berg, S Ten, Bogerd, M, Peters, E J, Ameloot, K, Russo, J J, Jentzer, J C, Kjaergaard, J, Meyer, M A S, Skrifvars, M B, Roberts, B W, Engstrom, A E, Vlaar, A P J, Otterspoor, L C, Henriques, J P S, Berg, Sanne ten , Bogerd, Margriet , Ameloot, Koen , Grand, Johannes , Russo, J.J., Jentzer, Jacob C. , Kjærgaard, Jesper , Meyer, M A S, Skrifvars, Markus B. , Engstrom, Annemarie E, Vlaar, Alexander P. J. , Otterspoor, L C, Henriques, José P S

Mayo Clinic

European Heart Journal | February 5, 2026 | Volume: 46 | Issue: Supplement_1 | Pages: No page available

10.1093/eurheartj/ehaf784.2251 Get It

Abstract Background/Introduction Optimal mean arterial pressure (MAP) in patients with acute myocardial infarction related out-of-hospital cardiac arrest (AMI-OHCA) and cardiogenic shock (AMI-CS) remains unclear. Randomized controlled trials (RCTs) comparing MAP targets have been performed in OHCA patients with presumed cardiac cause, but did not provide answers to the important question what MAP target would be optimal for the AMI-OHCA population. To our knowledge, no RCTs comparing MAP targets in AMI-CS patients have been performed. Purpose This comprehensive systematic review and meta-analysis aimed to evaluate the effect of low- and high-MAP levels on short-term mortality in AMI-OHCA and AMI-CS patients. Methods We conducted a systematic search of MEDLINE (OVID), EMBASE (OVID), CINAHL (Ebsco) and Cochrane CENTRAL databases. Eligible studies reported outcomes for AMI-OHCA or AMI-CS patients for at least two groups of different average MAP levels. Both RCTs and observational studies were eligible to ensure comprehensive data collection. Authors were proactively contacted for supplementary AMI data. Random-effects models were used to pool data. Results Of 7,728 screened studies, 57 were assessed for eligibility, and 11 were included in the final analysis (4 RCTs and 7 observational studies), encompassing 3,846 patients. The primary analysis included 1,251 AMI-OHCA patients. In the AMI-OHCA patients, no significant difference in short-term mortality was observed between low- and high-MAP groups in RCT (34.9% vs. 39.4%, RR 0.88, 95%-CI 0.70-1.10), observational-, and combined data. As only one of the 11 included studies reported on separate AMI-CS data, no meta-analyses of solely AMI-CS patients could be performed. Conclusions Our meta-analysis showed no significant difference in short-term mortality between low- and high-MAP levels in AMI-OHCA patients. Only one study in selected AMI-CS patients without OHCA patients was available. This highlights the importance of identifying tailored MAP strategies in both AMI-OHCA and AMI-CS patients.Flow chart of the selection of studies Short term mortality – AMI-OHCA patients
Recovery Potential in Patients After Cardiac Arrest Who Die After Limitations or Withdrawal of Life Support
Elmer, Jonathan, Ratay, Cecelia , Steinberg, Alexis , DiFiore-Sprouse, Sara, Case, Nicholas , De‐Arteaga, Maria , Cariou, Alain, Rossetti, Andrea O. , Doshi, Ankur , Molyneaux, Bradley J. , Maciel, Carolina B. , Leithner, Christoph , Sandroni, Claudio , Seder, David B., Taccone, Fabio Silvio, Soar, Jasmeet , Lascarrou, Jean-Baptiste, Nolan, Jerry P. , Hirsch, Karen G. , Berg, Katherine M. , Moseby‐Knappe, Marion , Skrifvars, Markus B., Kurz, Michael C. , Chae, Min Jung Kathy, Kurtz, Pedro, Geocadin, Romergryko G. , Agarwal, Sachin , May, Teresa , Olasveengen, Theresa M. , Group, Optimizing Recovery Prediction After Cardiac Arrest (ORCA) Study, Cariou, Alain , Greer, David M., Seder, David B., Naito, Hiromichi, Nolan, Jerry P., Elmer, Jonathan, Moseby-Knappe, Marion, Skrifvars, Markus B., Donnino, Michael W. , Sekhon, Mypinder, Coppler, Patrick J., Kurtz, Pedro, Seder, David B. , Lascarrou, Jean-Baptiste , Elmer, Jonathan, Coppler, Patrick J. , Fischhoff, Baruch , Rabinstein, Alejandro A. , Dezfulian, Cameron , Hsu, Cindy H. , Greer, David M. , Seder, David B., Guyette, Francis Xavier , Naito, Hiromichi , Skrifvars, Markus B., Chae, Minjung Kathy , Sekhon, Mypinder S. , Johnson, Nicholas James , Kurtz, Pedro, Callaway, Clifton W. , Group, Optimizing Recovery Prediction After Cardiac Arrest (ORCA) Study, Greer, David M., Seder, David B., Naito, Hiromichi, Nolan, Jerry P., Elmer, Jonathan, Moseby-Knappe, Marion, Skrifvars, Markus B., Coppler, Patrick J., Kurtz, Pedro

Mayo Clinic

JAMA Network Open | March 26, 2025 | Volume: 8 | Issue: 3 | Pages: e251714

10.1001/jamanetworkopen.2025.1714 | PMID 40131275 Get It

ImportanceUnderstanding the relationship between patients’ clinical characteristics and outcomes is fundamental to medicine. When critically ill patients die after withdrawal of life-sustaining therapy (WLST), the inability to observe the potential for recovery with continued aggressive care could bias future clinical decisions and research.ObjectiveTo quantify the frequency with which experts consider patients who died after WLST following resuscitated cardiac arrest to have had recovery potential if life-sustaining therapy had been continued.Design, Setting, and ParticipantsThis prospective cohort study included comatose adult patients (aged ≥18 years) treated following resuscitation from cardiac arrest at a single academic medical center between January 1, 2010, and July 31, 2022. Patients with advanced directives limiting critical care or who experienced cardiac arrest of traumatic or neurologic etiology were excluded. An international cohort of experts in post-arrest care based on clinical experience and academic productivity was identified. Experts reviewed the cases between August 24, 2022, and February 11, 2024.ExposurePatients who died after WLST.Main Outcome and MeasuresThree or more experts independently estimated recovery potential for each patient had life-sustaining treatment been continued, using a 7-point numerical ordinal scale. In the primary analysis, which involved the patient cases with death after WLST, a 1% or greater estimated recovery potential was considered to be clinically meaningful. In secondary analyses, thresholds of 5% and 10% estimated recovery probability were explored.ResultsA total of 2391 patients (median [IQR] age, 59 [48-69] years; 1455 men [60.9%]) were included, of whom 714 (29.9%) survived to discharge. Cases of uncertain outcome (1431 patients [59.8%]) in which WLST preceded death were reviewed by 38 experts who rendered 4381 estimates of recovery potential. In 518 cases (36.2%; 95% CI, 33.7%-38.7%), all experts believed that recovery potential was less than 1% if life-sustaining therapies had been continued. In the remaining 913 cases (63.8%; 95% CI, 61.3%-66.3%), at least 1 expert believed that recovery potential was at least 1%. In 227 cases (15.9%; 95% CI, 14.0%-17.9%), all experts agreed that recovery potential was at least 1%, and in 686 cases (47.9%; 95% CI, 45.3%-50.6%), expert estimates differed at this threshold.Conclusions and RelevanceIn this cohort study of comatose patients resuscitated from cardiac arrest, most who died after WLST were considered by experts to have had recovery potential. These findings suggest that novel solutions to avoiding deaths based on biased prognostication or incomplete information are needed.